Four Sulfonylureas Tied to Deaths in Prior MI Patients: Rate 33%-43% higher than metformin.

BARCELONA — Four widely prescribed oral sulfonylurea drugs are associated with significantly increased risk of all-cause mortality compared with metformin in type 2 diabetic patients having a history of MI, according to a comprehensive Danish national cohort study.